Metabolix (YTEN)
(Delayed Data from NSDQ)
$0.22 USD
-0.02 (-7.20%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.22 0.00 (-0.81%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.22 USD
-0.02 (-7.20%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.22 0.00 (-0.81%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Corteva, Inc. (CTVA) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 24.73% and 3.26%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ADT and CarMax have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
ADT and CarMax have been highlighted as Zacks Bull and Bear of the Day.
3 Under-$3 Consumer Staple Stocks Wall Street Analysts Recommend Buying
by Vrishali Bagree
Yield10 Bioscience (YTEN), The Alkaline Water Company (WTER) and Benson Hill (BHIL) are low-priced and well-ranked consumer staple companies, which look well-placed for 2023 on the back of their robust fundamentals.
Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -1.43% and 26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Corteva, Inc. (CTVA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 47.83% and 7.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Metabolix, Inc. (YTEN) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -1.45% and 37.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Corteva, Inc. (CTVA) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 11.56% and 1.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Archer Daniels Midland (ADM) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
ADM (ADM) delivered earnings and revenue surprises of 22.86% and 7.98%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Archer Daniels Midland, Corteva, Yield10 Bioscience, Adecoagro and Calavo Grower
by Zacks Equity Research
Archer Daniels Midland, Corteva, Yield10 Bioscience, Adecoagro and Calavo Grower have been highlighted in this Industry Outlook article.
5 Stocks to Watch on Robust Agriculture Operations Industry Trends
by Rajani Lohia
The Agriculture - Operations industry shows potential on solid demand trends, organic product growth and innovation ability. Players like ADM, CTVA, YTEN, AGRO and CVGW have placed themselves well.
Metabolix, Inc. (YTEN) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -3.03% and 10.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of 22.22% and -57.99%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Metabolix, Inc. (YTEN) Report Negative Q3 Earnings? What You Should Know
by Zacks Equity Research
Metabolix, Inc. (YTEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Metabolix, Inc. (YTEN) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -20.75% and -17.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Metabolix, Inc. (YTEN) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Metabolix, Inc. (YTEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Agriculture Operations Stocks Countering Challenges Facing the Industry
by Rajani Lohia
Although coronavirus-led disruptions continue to pose challenges for the Agriculture - Operations Industry, companies like YTEN, CTVA, ADM and AGRO have placed themselves well with innovations and investments.
4 Agriculture Operations Stocks Set to Dodge Near-Term Industry Challenges
by Zacks Equity Research
Coronavirus-led disruptions in exports and supply chain, and changing consumer habits have upset the Agriculture - Operations Industry. Swiftly adjusting to changing preferences and challenges, ADM, CTVA and YTEN are players that have placed themselves well.
Company News for Mar 11, 2020
by Zacks Equity Research
Companies In The News Are: AVID, GPX, YTEN, SFIX
The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail
by Zacks Equity Research
The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail
Global Economic Growth Concerns Resurface: 5 Safe Picks
by Nalak Das
Concerns over slowing global growth have contributed to this uncertainty and dented investors' confidence to some extent.